|
|
| Line 143: |
Line 143: |
|
| |
|
| {{Discussion}} | | {{Discussion}} |
| ===Questions about the criteria change?===
| |
| *under the heading notes to collectors:"NOTE that ETT secretion(sputum) culture is NOT part of the criteria -- the reason is that sputum is virtually never culture negative in intubated patients, even without infection." We will still put the ETT pathogen in the diagnostic codes if it is available, even though the positive culture is not part of the criteria.
| |
|
| |
|
|
| |
| *Under new CDC list:Why would it be acceptable to take ETT cultures (with blood) for immunocompromised patients? Wouldn't those ETT cultures be just as contaminated as any other patients? Shouldn't they also have cultures from an acceptable source?
| |
| * It is only acceptable to use this for matching candida only. Not for all types of culture. This item only relates to candida. --[[User:LKolesar|LKolesar]] 09:55, 2018 July 26 (CDT)
| |
|
| |
| *When talking about BAL are you talking about secretions obtained via bronch?
| |
| *Yes, a BAL is a bronch. For clarification, regarding the "quantitative culture", Dr. Garland says this is not done very often if ever and he has actually never seen one done at HSC. Most bronchs are not "quantitative" so for most intents and purposes a BAL culture is not valid for use in the VAP criteria unless candida is cultured in immunocompromised patients only and only if the patient also has a matching blood culture. --[[User:LKolesar|LKolesar]] 09:55, 2018 July 26 (CDT)
| |
|
| |
|
| {{ICD10 footer}} | | {{ICD10 footer}} |
| {{EndPlaceHolder}} | | {{EndPlaceHolder}} |